Tonix Pharmaceuticals Q1 EPS $(2.84) Beats $(3.37) Estimate, Sales $2.43M Miss $2.55M Estimate

Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(2.84) per share which beat the analyst consensus estimate of $(3.37) by 15.73 percent. This is a 99.51 percent increase over losses of $(576.00) per share from the same period last year. The company reported quarterly sales of $2.43 million which missed the analyst consensus estimate of $2.55 million by 4.75 percent. This is a 2.14 percent decrease over sales of $2.48 million the same period last year.